Abstract Background Type 2 Diabetes (T2D) is influenced by genetic, environmental, and
ageing factors. Ageing pathways exacerbate metabolic diseases. This study aimed to …

The pathogenesis of type 2 diabetes (T2D) might change with increasing age. Here, we
used a stratification based on age of diagnosis to gain insight into the genetics and causal …

Dyslipidemia has been associated with type 2 diabetes, but it remains unclear whether
dyslipidemia plays a causal role in type 2 diabetes. We aimed to examine the association …

Background and aims Type 2 diabetes mellitus (T2DM) is a condition defined by
hyperglycaemia, but also often presents with dyslipidaemia and suppressed HDL …

Although hyperlipidemia is traditionally considered a risk factor for type 2 diabetes (T2D),
evidence has emerged from statin trials and candidate gene investigations suggesting that …

Diabetic dyslipidemia is a common condition in patients with Type 2 diabetes mellitus
(T2DM). However, with the increasing application of statins which mainly decrease low …

Aims To evaluate the type 2 diabetes mellitus (T2DM) risk of individuals with different types
of dyslipidaemia and compare the predictive value of distinct lipid parameters in predicting …

OBJECTIVE To identify the clinical and genetic factors that explain why the rate of diabetes
progression is highly variable between idividuals following diagnosis of type 2 diabetes …

Objective Time-dependent covariates are generally available as longitudinal data were
collected periodically in the cohort study. To examine whether time-dependent triglyceride to …

Background—We assessed whether 234 established dyslipidemia-associated loci modify
the effects of metformin treatment and lifestyle intervention (versus placebo control) on lipid …